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ABSTRACT	
	Quantitative	 susceptibility	 mapping	 (QSM)	 has	 recently	 emerged	 as	 a	 novel	magnetic	resonance	imaging	(MRI)	method	to	detect	non-haem	iron	deposition,	calcifications,	 demyelination	 and	 vascular	 lesions	 in	 the	 brain.	 It	 has	 been	suggested	 that	QSM	 is	more	 sensitive	 than	 the	more	 conventional	 quantifiable	MRI	measure,	namely	the	transverse	relaxation	rate,	R2*.	Here,	we	conducted	the	first	 high-resolution,	 whole-brain,	 simultaneously	 acquired,	 comparative	 study	of	the	two	techniques	using	7	Tesla	MRI.	We	asked	which	of	the	two	techniques	would	be	more	 sensitive	 to	 explore	 global	 differences	 in	 tissue	 composition	 in	elderly	adults	relative	to	young	subjects.	Both	QSM	and	R2*	revealed	strong	age-related	differences	in	subcortical	regions,	hippocampus	and	cortical	grey	matter,	particularly	 in	 superior	 frontal	 regions,	 motor/premotor	 cortices,	 insula	 and	cerebellar	regions.	Within	the	basal	ganglia	system—but	also	hippocampus	and	cerebellar	dentate	nucleus—,	QSM	was	 largely	 in	 agreement	with	R2*	with	 the	exception	 of	 the	 globus	 pallidus.	 QSM,	 however,	 provided	 superior	 anatomical	contrast	 and	 revealed	 age-related	 differences	 in	 the	 thalamus	 and	 in	 white	matter,	 which	 were	 otherwise	 largely	 undetected	 by	 R2*	 measurements.	 In	contrast,	in	occipital	cortex,	age-related	differences	were	much	greater	with	R2*	compared	to	QSM.	The	present	study,	therefore,	demonstrated	that	 in	vivo	QSM	using	 ultra-high	 field	 MRI	 provides	 a	 novel	 means	 to	 characterize	 age-related	differences	 in	 the	 human	 brain,	 but	 also	 combining	 QSM	 and	 R2*	 using	multi-gradient	recalled	echo	imaging	can	potentially	provide	a	more	complete	picture	of	 mineralization,	 demyelination	 and/or	 vascular	 alterations	 in	 aging	 and	disease.		
1.	INTRODUCTION		Iron	 is	 involved	 in	 numerous	 fundamental	 neural	 processes	 such	 as	 oxygen	transportation,	DNA	synthesis,	mitochondrial	 respiration,	myelin	production	as	well	 as	 synthesis	 and	metabolism	 of	 neurotransmitters	 (Ward	 et	 al.,	 2014).	 In	aging,	 selective	 accumulation	 of	 iron—largely	 bound	 to	 ferritin	 and	neuromelanin—occurs	 in	 numerous	 brain	 regions	 with	 possible	 neurotoxic	consequences	 such	 as	 oxidative	 damage	 and	 cell	 death	 (Ward	 et	 al.,	 2014).	Whilst	 the	 mechanisms	 underlying	 this	 accumulation	 are	 not	 yet	 fully	understood,	 measuring	 brain	 iron	 may	 provide	 an	 important	 insight	 into	understanding	 the	 neurodegenerative	 processes	 occurring	 in	 aging	 and	neurological	disease.			Previous	studies	using	either	post	mortem	(Hallgren	and	Sourander,	1958)	or	in	
vivo	 iron-sensitive	MRI	 techniques	 (Acosta-Cabronero	et	 al.,	 2016;	Bartzokis	 et	al.,	2007;	Haacke	et	al.,	2007;	Hasan	et	al.,	2012;	Pfefferbaum	et	al.,	2009;	Raz	et	al.,	 2007)	 have	 revealed	 that	 iron	 levels	 and	 its	 rate	 of	 accumulation	 are	heterogeneous	in	the	human	brain.	Furthermore,	 iron	deposition	may	correlate	with	cognitive	impairment	(Daugherty	et	al.,	2015;	Ghadery	et	al.,	2015;	Penke	et	al.,	 2012)	 and	 slowing	of	motor	performance	 (Cass	 et	 al.,	 2007;	Li	 et	 al.,	 2015;	Sullivan	et	al.,	2009),	though	it	is	unclear	whether	this	is	cause	or	consequence.	Since	 aging	 is	 the	major	 risk	 factor	 for	many	neurodegenerative	diseases,	 age-related	 accumulation	 of	 iron	 may	 be	 an	 important	 factor	 that	 contributes	 to	
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neurodegenerative	 pathology	 (Ward	 et	 al.,	 2014).	 This	 notion	 has	 been	supported	by	post	mortem	and	 in	vivo	human	studies	identifying	abnormal	iron	deposition	 in	 neurodegenerative	 diseases	 such	 as	 Alzheimer’s	 disease	 (AD)	(Cornett	 et	 al.,	 1998;	 Bartzokis	 et	 al.,	 2000)	 and	 Parkinson’s	 disease	 (PD)	(Bartzokis	et	al.,	1999;	Bunzeck	et	al.,	2013;	Sofic	et	al.,	1991).				To	date,	the	T2*	transverse	relaxation	time,	or	its	inverse	rate,	R2*	(=1/T2*),	has	been	 routinely	 utilised	 as	 a	 surrogate	 marker	 to	 assess	 brain	 iron	 deposition	with	both	 in	vivo	 (Gelman	et	al.,	1999;	Péran	et	al.,	2009;	Yao	et	al.,	2009)	and	
post	mortem	data	(Langkammer	et	al.,	2010),	demonstrating	a	linear	relationship	between	R2*	and	iron	concentration	in	deep	grey	matter	(GM).	R2*,	however,	 is	known	to	be	a	composite	measure	sensitive	to	T2/diffusion	effects	and	magnetic	field	 inhomogeneities.	 R2*	 can	 be	 driven	 by	 intravoxel	 spin	 dephasing	 in	 the	vicinity	of	 steep	 field	 gradients	 (Fernández-Seara	 and	Wehrli,	 2000)	 stemming	from	the	focal	mineralization	of	deep	GM	nuclei;	it	is	also	vulnerable	to	spurious	observations	from	external	sources	such	as	air	in	cranial	cavities	and	other	non-local	 field	 disturbances	 (Deistung	 et	 al.,	 2013).	 Recently,	 a	 novel	 technique	termed	quantitative	 susceptibility	mapping	 (QSM)	has	been	proposed	 to	 try	 to	overcome	 the	 non-locality	 of	 magnetic	 field	 fluctuations.	 QSM	 provides	 a	quantitative	and	local	anatomical	contrast	by	estimating	magnetic	susceptibility	sources	from	their	signature	on	the	MRI	signal	phase	(de	Rochefort	et	al.,	2008).	QSM	results	have	shown	agreement	with	both	post-mortem	 iron	measurements	(Langkammer	 et	 al.,	 2012;	 Sun	 et	 al.,	 2015;	 Zheng	 et	 al.,	 2013)	 and	 additional	iron-sensitive	 MRI	 techniques	 (Bilgic	 et	 al.,	 2012;	 Poynton	 et	 al.,	 2015).	Furthermore,	 at	 ultra	 high-field	 strength	 (B0≥7	 Tesla),	 QSM	 has	 demonstrated	superb	 anatomical	 contrast	 and	 superior	 delineation	 of	 GM	 substructures	compared	 to	 R2*	 and	 conventional	 iron-sensitive	 measures	 (Deistung	 et	 al.,	2013;	Lotfipour	et	al.,	2012).		Studies	 comparing	QSM	and	R2*	 as	 surrogate	markers	of	brain	 iron	deposition	within	cortical	regions	of	healthy	young	individuals	(Deistung	et	al.,	2013)	and	in	subcortical	 regions	 in	PD	(Barbosa	et	al.,	2015),	have	shown	QSM	may	provide	superior	sensitivity	to	detect	differences	in	local	GM.	No	study	to	date,	however,	has	 directly	 compared	 QSM	 and	 R2*	 differences	 as	 a	 result	 of	 normal	 aging.	Furthermore	 both	 aforementioned	 studies	 were	 limited	 to	 regions-of-interest	(ROI)	analyses.	Yet,	recent	aging	 lifespan	studies	using	quantitative	multimodal	MRI	 (Callaghan	 et	 al.,	 2014)	 and	 QSM	 (Acosta-Cabronero	 et	 al.,	 2016)	 have	shown	 whole-brain	 analyses	 may	 be	 used	 to	 reveal	 global	 patterns	 of	 iron	distribution	that	may	otherwise	be	missed	in	pre-defined	ROI	analyses.			A	direct	whole-brain	comparison	of	QSM	and	R2*	is	important	not	only	because	they	 may	 show	 differential	 sensitivity	 to	 age-related	 differences	 in	 iron-rich	brain	regions,	but	also	because	they	may	be	differentially	affected	by	additional	pathological	 processes.	 Both	 are	 also	 substantially	 affected	 by	 variations	 in	myelin	density,	however	in	contrasting	ways.	R2*	increases	proportionally	to	the	concentration	 of	 both	 iron	 (Langkammer	 et	 al.,	 2010)	 and	 myelin	 (Lee	 et	 al.,	2012),	 whilst	 the	 two	 substances	 exert	 opposing	 effects	 on	 magnetic	susceptibility	 (Liu	 et	 al.,	 2011;	 Schweser	 et	 al.,	 2011)	 due	 to	 the	 strong	diamagnetic	 component	 driven	 by	 phospholipids	 in	 myelin	 membranes	
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(Langkammer	et	al.,	2012;	Li	et	al.,	2012).	QSM	and	R2*	are,	therefore,	unique	and	potentially	 complimentary	 contrasts	 to	 explore	 whole	 brain	 age-related	differences,	 chiefly	 owing	 to	 their	 differential	 sensitivities	 to	 iron	 and	 myelin	content	 (Fukunaga	 et	 al.,	 2010);	 they	may	 also	 be	 differentially	modulated	 by	other	forms	of	mineralization	such	as	calcifications	(Chen	et	al.,	2014),	by	brain	oxygen-saturation	 levels	 (Rodrigue	 et	 al.,	 2011)	 and/or	 vascular	 pathology	(Reichenbach	et	al.,	2015).		Here,	 we	 conducted	 the	 first	 high-resolution,	 whole-brain,	 simultaneously	acquired,	 comparative	 QSM	 versus	 R2*	 imaging	 study	 using	 7	 Tesla	 (7T)	MRI.	QSM	 and	 R2*	 measurements—inferred	 from	 the	 same	 multi-gradient	 recalled	echo	 (GRE)	acquisition—were	 first	qualitatively	compared	using	a	whole-brain	cluster-wise	 approach,	 and	 were	 then	 more	 directly	 contrasted	 with	 data	extracted	from	a	whole-brain	ROI	parcellation.	
	
2.	METHODS		
2.1	Study	subjects	
	A	total	of	20	healthy	older	adults	aged	64	to	75	years	of	age	(mean:	70	±	1;	11	females	and	9	males,	years	of	education:	16	±	3)	and	20	younger	adults	aged	22	–	28	 years	 of	 age	 (mean:	 24	 ±	 2;	 11	 females	 and	 9	 males)	 were	 recruited,	 and	written	informed	consent	was	obtained	from	all	participants	in	accordance	with	the	Declaration	of	Helsinki.	The	study	received	ethical	approval	from	the	Faculty	of	Medicine	at	 the	University	of	Magdeburg.	All	older	adults	were	a	subset	of	a	larger	cohort	previously	screened	to	ensure	intact	global	cognitive	performance	using	 a	 brief	 neuropsychological	 battery,	 exclude	 neurological	 or	 major	psychiatric	illness	and	cases	of	white	matter	(WM)	ischaemia	(Acosta-Cabronero	et	al.,	2016).	Prior	 to	 recruitment	 into	 this	 study,	T2-weighted	 images	acquired	with	 3T	 MRI	 were	 visually	 inspected	 to	 exclude	 severe	 brain	 abnormalities.	Vascular	 pathology	was	 assessed	 on	T2-weighted	MRI	 by	 applying	 the	 Fazekas	scale	 (Fazekas	et	al.,	1987)	whereby	deep	or	periventricular	scores	of	≥2	were	excluded.	Mild	lesions	(i.e.	small,	probable	calcium	deposits),	however,	were	not	excluded	 and	 deemed	 a	 feature	 of	 normal	 aging.	 No	 subjects	 demonstrated	evidence	 of	 micro-haemorrhages.	 Data	 on	 vascular	 risk	 factors	 was	 collected	from	all	 subjects,	 namely	 history	 of	 hypertension,	 heart	 attack	 and	diabetes	 in	addition	to	height	and	weight.	Two	older	participants	had	been	diagnosed	with	hypertension	and	one	subject	was	obese	(body-mass	index	>30).	No	subjects	had	history	of	diabetes	or	heart	attack.		
2.2	Imaging	protocol	
	All	 subjects	were	 scanned	 on	 a	 Siemens	MAGNETOM	 7T	 system	 using	 a	 Nova	Medical	 (Willmington,	 MA)	 32-channel	 reception	 head-coil.	 Whole-brain	susceptibility	weighted	imaging	(SWI)	consisted	of	a	3D	GRE	sequence	with	four	monopolar	 readouts	 centred	 at	 8,	 13,	 18	 and	 23	 ms	 after	 (3D	 slab-selective)	excitation;	 receiver	 bandwidth	was	 300	Hz/pixel	 for	 each	 acquired	 echo.	Note	that	 only	 the	 first	 echo	 was	 fully	 flow	 compensated.	 Additional	 imaging	parameters	 were:	 repetition	 time	 (TR)=28	 ms;	 flip	 angle=12°;	 3D	 matrix	
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dimensions,	320×320×88	(straight-axial	slices)	and	voxel	size,	0.8×0.8×1.6	mm3,	with	 7/8	 phase	 and	 slice	 k-space	 undersampling	 giving	 a	 scan	 time	 of	 10:05	minutes.	The	prescribed	matrix	size	ensured	whole-brain	coverage,	while	 large	voxels	prioritised	contributions	from	non-venous	structures	with	high	signal-to-noise	 ratio.	 The	 distinct	 advantage	 of	 this	 multi-echo	 approach	 is	 that	quantitative	 R2*	 maps	 and	 QSM	 can	 be	 reconstructed	 from	 the	 same	 dataset,	readily	 enabling	 direct	 comparison	 between	 both	 measurements.	 The	disadvantages,	however,	are	that	flow	effects	are	more	apparent	than	in	single-echo	 fully	 flow	 compensated	 acquisitions,	 and	 that	 blurring	 due	 to	 subject	motion	or	phase	errors	are	more	prevalent	due	to	longer	readout	and	total	scan	times.			A	T1-weighted	3D-MPRAGE	was	 also	 acquired	 in	 the	 same	 scanning	 session	 to	independently	resolve	 the	underlying	brain	anatomy.	The	 following	acquisition	parameters	were	used:	 inversion	time	of	1050	ms;	 flip	angle	was	5°;	echo	time	(TE)	of	2.09	ms;	receiver	bandwidth	was	230	Hz/pixel;	echo	spacing	was	6.1	ms;	and	 TR=2000	ms.	 3D	matrix	 dimensions	 were	 320×320×224	 (straight-sagittal	slice	 orientation	 with	 0.5-mm	 inter-slice	 gap),	 7/8	 partial	 Fourier,	 and	0.8×0.8×0.8	mm3	voxel	size.	GRAPPA	was	also	enabled	with	acceleration	factor	of	2	and	32	reference	lines.			To	minimise	motion	and	 increase	 inter-subject	 reproducibility	 in	positioning,	a	thin	pillow	was	placed	on	the	base	of	the	coil	surrounding	the	sides	and	the	back	of	the	head.	
	
2.3	QSM	reconstruction	
	In	 order	 to	 reduce	 phase	 errors	 in	 the	 combination	 of	 multi-echo	 data,	 we	estimated	the	off-resonance	frequency	from	the	complex	GRE	signal	evolution	by	solving	a	nonlinear	least-squares	fitting	problem	(Liu	et	al.,	2013).	Phases	were	subsequently	unwrapped	with	a	direct	continuous	Laplacian	method	(Schofield	&	Zhu,	2003),	although	one	must	note	this	method	may	introduce	some	errors	in	the	vicinity	of	vasculature	(Haacke	et	al.,	2015).	Then,	locally	sourced	inductions	(i.e.	 foreground	 field	shifts)	were	revealed	 through	background	 field	extraction	with	the	SHARP	algorithm	(sphere	radius	of	5	mm;	Schweser	et	al.,	2011).	Prior	to	applying	SHARP,	BET2	(Smith,	2002)	with	fractional	threshold	set	to	0.2	was	used	 to	 estimate	 the	 brain	 boundary	 from	 the	 radio-frequency	 (RF)	 bias-corrected	 (Tustison	 et	 al.,	 2010)	 T2*-weighted,	 combined	 magnitude	 image.	Finally,	 for	 conditioning	 the	 susceptibility	 restoration	 problem	 from	 the	background-field	 corrected	 phase	 images,	 the	 iterative,	 morphology-enabled,	non-linear	dipole	inversion	(MEDIN)	solver	with	dynamic	model	error	reduction	(MERIT)	 was	 applied	 (Liu	 et	 al.,	 2013)	 –	 source	 code	 available	 from:	http://weill.cornell.edu/mri/pages/qsm.html.	MEDIN	 incorporates	 the	ℓ!-norm	of	 a	 total-variation	 operation	 to	 the	 susceptibility	 distribution	 as	 a	 penalty	 to	“compartmentalize”	 (by	 encouraging	 sparsity)	 an	 otherwise	 data-consistent	solution.	The	regularising	term	was	also	aided	by	morphological	information,	i.e.	element-wise	 multiplication	 with	 a	 gradient	 mask	 conforming	 to	 the	 30%	greatest	GRE	magnitude	gradients.	The	regularisation	parameter	(λ=1,000)	was	the	median	resulting	from	five	randomly	selected	datasets,	where—using	λ=500	
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steps—the	 consistency-term	 residual	 was	 matched	 to	 an	 estimate	 of	 the	foreground	field	noise	level	(Morozov,	1966).	Note	that	with	the	exception	of	the	initial	multi-echo	combination	step,	the	reconstruction	pipeline	is	essentially	the	same	as	that	described	in	a	recent	3T	study	(Acosta-Cabronero	et	al.,	2016).		
2.4	QSM	reference	normalization		The	 magnetic	 dipole	 kernel	 operation	 used	 for	 inversion	 eliminates	 direct	current	(or	DC)	offsets;	thus,	QSM	values	are	typically	normalized	to	a	reference	region	in	an	attempt	to	re-adjust	such	an	offset.	Note,	however,	that	there	is	no	consensus	at	present	on	reference-region	selection.	Whilst	manual	selection	may	introduce	 inconsistency,	 automated	 methods	 are	 yet	 to	 be	 proposed.	 In	 a	previous	 study,	 we	 demonstrated	 that	 aging	 effects	 on	 QSM	 far	 outweigh	 the	impact	of	such	a	reference	adjustment	(Acosta-Cabronero	et	al.,	2016),	indicating	it	 is	 appropriate	 from	 a	 reproducibility	 standpoint,	 to	 report	 non-normalized	values;	 nevertheless,	 we	 additionally	 performed	 the	 subsequent	 analyses	with	reference-normalized	 QSM	 values	 to	 independently	 confirm	 this	 observation.	Normalization	 consisted	 of	 a	 direct	 subtraction	 by	 the	median	QSM	 value	 of	 a	confluent	 region	 with	 low	 non-normalised	 variance.	 The	 reference	 region—located	in	parietal	WM	far	from	a	GM/WM	boundary—was	traced	with	the	aid	of	a	study-wise	map	of	QSM	variance	(relative	to	the	population	mean)	saturated	at	an	upper	threshold	of	0.005.	Notably,	in	agreement	with	our	previous	3T	study,	non-normalised	signed	QSM	values	revealed	statistically	comparable	aging	effect	sizes	 to	 reference-normalised	QSM	data	 (Friedman’s	 test;	 not	 significant;	 (χ2	 =	0.60;	p	=	0.439).			
2.5	Absolute	QSM			In	 the	present	 study,	we	also	propose	 taking	 the	absolute	value	of	 signed	QSM	data	as	an	alternative	magnetic	susceptibility	related	metric.	The	impact	of	this	new	 approach	 is	 two-fold:	 (i)	 it	 renders	 QSM	 data	 more	 comparable	 to	 the	positive-real	 nature	 of	 R2*	 by	 additively	 collapsing	 effects	 from	 paramagnetic	and	diamagnetic	substances	into	an	unsigned	measure	of	“mineralization”;	but	it	also,	 (ii)	 reduces	 the	 spatial	 gradient	 of	 blooming	 effects	 often	 observed	 in	susceptibility	 maps	 (i.e.	 residuals	 of	 the	 QSM	 inversion	 that	 originate	 from	strongly	 reactive	 magnetic	 species	 such	 as	 iron).	 Taking	 the	 absolute	 to	 QSM	values,	thus,	aimed	at	minimising	the	spurious	impact	that	such	boundary	effects	have	both	on	regional	extractions	and	on	the	application	of	a	smoothing	kernel	(required	 to	correct	 for	co-registration	errors	and	other	 imperfections	prior	 to	whole-brain	analysis).	It	must	be	highlighted,	however,	that	the	disadvantage	of	absolute	 QSM	 is	 that	 it	 cannot	 distinguish	 greater	 diamagnetism	 (e.g.	calcifications)	 from	greater	paramagnetism	(e.g.	 iron	deposition);	 it	cannot	 tell,	thus,	 the	 type	 of	 mineralisation.	 Notably,	 we	 found	 subcortical	 effect	 size	differences	 between	 signed	 QSM	 and	 absolute	 QSM	 data	 in	 the	 present	 aging	cohort	(χ2	=	52.27;	p<0.001),	which	suggest	they	might	be	capturing	differential	magnetostatic	interactions	of	counteracting	species	such	as	iron	and	calcium	or	myelin.	 Both	 metrics	 were	 thus	 studied	 and	 interpreted	 in	 combination.	 In	addition,	 in	 order	 to	 provide	 further	 insights	 into	 the	 exact	
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(diamagnetic/paramagnetic)	 origins	 of	 age-related	 effects,	 positive-only	 and	negative-only	QSM	maps	were	also	analysed.	
	
2.6	R2*	mapping	
	MR	signal	decays	across	four	T2*	weighted	images	were	(voxel-by-voxel)	fitted	to	a	mono-exponential	model	(S=S0	e-TE/T2*)	using	a	previously	validated,	non-linear	least-squares	fitting	routine	(Acosta-Cabronero	and	Hall,	2009).	For	robustness,	starting	values	were	approximated	with	a	linear	fit	on	the	logarithm	of	the	signal	magnitude	 of	 the	 first	 two	 echoes.	 One	 should	 note,	 however,	 that	 numerous	studies	have	described	the	deleterious	impact	of	noise	in	scenarios	of	low	signal	where	 the	 Rician	 nature	 of	 the	 signal	 magnitude	 may	 artificially	 elevate	 true	values	(Gudbjartsson	and	Patz,	1995;	Cardenas-Blanco	et	al.,	2008).	In	particular	at	 ultra-high	 field,	 such	 scenarios	 may	 unfold	 for	 late	 echoes,	 potentially	resulting	 in	the	underestimation	of	R2*	values.	 In	order	to	assess	whether	such	bias	 affected	 our	 measurements,	 a	 large	 rectangular	 noise	 region	 (280×20)	outside	the	brain	posteriorly—avoiding	contamination	along	the	phase-encoding	direction—was	selected	(see	Inline	Supplementary	Fig.	1A),	and	the	noise	floor	was	set	to	7	times	the	standard	deviation	of	the	real	signal	in	this	region	(7σG).	The	 same	 noise	 region	 was	 used	 for	 all	 subjects,	 ensuring	 through	 visual	inspection	 its	 correct	 placement.	 For	 all	 iron-rich	 nuclei	 studied	 here,	 signal	magnitude	 at	 the	 last	 echo,	 i.e.	 TE=23	 ms,	 was	 greater	 than	 the	 noise	 floor	suggesting	estimated	R2*	values	were	unbiased	by	the	effect	of	noisy	signals	(see	Inline	 Supplementary	 Fig.	 1B).	 Nevertheless,	 individual	 data	 points	 below	 the	noise	floor	were	excluded	from	the	relaxometry	calculation.			
	
	
Inline	Supplementary	Figure	1.	Data-quality	assurance.	(A)	A	large	rectangular	ROI	 in	 a	 posterior	 region	 outside	 the	 brain	was	 selected	 to	 estimate	 the	 noise	level.	 (B)	 Example	 signal	 decay	 quantified	 from	 four	 back-to-back	 gradient	echoes	 (equally	 spaced	 every	 5	 ms	 from	 8	 to	 23	 ms)	 and	 plotted	 on	 a	 semi-logarithmic	 scale.	 Notably,	 the	 average	 T2*-weighted	 signal	 for	 the	 globus	pallidus	 (GP)—i.e.	 the	 brain	 structure	 with	 the	 shortest	 average	 T2*	 value—remained	well	above	the	noise	floor.	
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2.7	QSM	and	R2*	spatial	standardisation	
	RF-bias	 corrected	 with	 N4-ITK	 (Tustison	 et	 al.,	 2010)	 MPRAGE	 images	 were	standardised	 (to	 a	 study-wise	 space)	 by	way	of	 a	 parallel	 routine	 for	 template	calculation	 provided	 in	 ANTs	 v2.1	 (Avants	 et	 al.,	 2008).	 Simultaneous	 co-registrations	were	 driven	 by	 a	 cross-correlation	minimization	 performed	 over	three	resolutions	with	a	maximum	of	90	iterations	at	the	coarsest	level,	30	at	the	next	coarsest	and	90	at	full	resolution;	template	update	step	size	was	set	to	0.1	mm.	Four	rigid-then-affine	iterations	were	followed	by	six	full	runs	of	the	above	non-linear	multi-resolution	routine	to	ensure	stable	convergence.	Subsequently,	bias-corrected	T2*-weighted	magnitude	images	for	each	SWI	dataset	were	affine	co-registered	using	ANTs	to	their	corresponding	MPRAGE	volume.	T2*-weighted,	R2*	 and	 QSM	 spatial	 standardisation	 was	 achieved	 through	 the	 warp	composition	of	the	above	transformations	and	third-order	b-spline	interpolation	(average-population	templates	are	shown	in	Inline	Supplementary	Fig.	2).	
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Inline	 Supplementary	 Figure	 2.	 Study-wise	 templates	 for	 anatomical	 T1-weighted	MRI,	T2*-weighted	MRI,	 transverse	relaxation	rate	(R2*)	mapping	and	quantitative	susceptibility	mapping	(QSM).		
	
2.8	Co-registration	performance	and	data	dispersion	
	The	 analyses	 reported	 below	 strongly	 rely	 on	 the	 performance	 of	 the	 co-registration	 routine	 since	 warping	 inaccuracies	 arising	 from	 heterogeneous	behaviors	 induced	by	 atrophy,	 venous	 idiosyncrasies	 or	 imaging	 artifacts,	may	lead	to	abnormally	high	QSM	variance.	These	errors,	however,	are	characterised	by	the	spatial	distribution	of	unphysical	high	relative	variances.		In	this	study,	QSM	variances	were	saturated	at	5%	(relative	to	the	absolute	mean	across	subjects),	i.e.	five	times	greater	than	that	measured	in	the	dentate	nucleus	–	the	subcortical	structure	with	the	greatest	implicit	variance	(see	Table	2	in	the	results	 section).	 As	 can	 be	 seen	 from	mean	 and	 relative	 variance	maps	 across	N=40	 subjects	 (plotted	 in	 Fig.	 1),	 signed	 QSM	 returned	 the	 greatest	 variances	chiefly	 near	 vasculature,	 and	within	 or	 in	 the	 vicinity	 of	 several	 cortical	 areas	(Fig.	1B).	Except	for	the	thalamus—composed	of	heterogeneous	sub-nuclei—and	hippocampus,	 all	ROIs	were	devoid	of	 large	 signed	QSM	deviations.	Taking	 the	absolute	 to	QSM,	as	expected,	resulted	 in	reduced	 inter-subject	variance	across	the	cortex,	 though	spurious	dispersion	could	still	be	observed	 in	 the	vicinity	of	the	vasculature	(Fig.	1D).	R2*	yielded	overall	the	slightest	relative	variances	(Fig.	1F).	 Nevertheless,	 for	 all	 types	 of	 measurement,	 almost	 all	 subcortical	 ROIs	including	 small	 structures	 such	 as	 the	 RN,	 SN	 and	 STN	 avoided	 overlapping	structural	boundaries	and	regions	of	high	variance.	The	cortex	was	expected	to	be	 more	 problematic	 with	 signed	 QSM	 due	 to	 strong	 GM/WM	 susceptibility	gradients.	For	absolute	QSM	and	R2*,	however,	the	majority	of	the	cortical	ribbon	was	 shown	 to	 be	 devoid	 of	 spurious	 variability	 due	 to	 less	 abrupt	 spatial	variations	–	qualitatively	illustrating	their	value	to	study	the	cortex	with	whole-brain	analysis	methods.			
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Figure	1.	Mean	and	relative	variance	maps	across	N=40	subjects	 in	study-wise	space	for	(A,	B)	signed	QSM,	(C,	D)	absolute	QSM	and	(E,	F)	R2*,	respectively.	Blue	
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contours	 represent	 the	 subcortical	 regions	 of	 interest	 from	which	 quantitative	data	was	extracted	in	this	study.		
	
2.9	Whole-brain	QSM	and	R2*	analyses	
	Age	 differences	were	 estimated	 for	 the	whole	 brain	 by	 computing	 two-sample	permutation	 statistics	 using	 Randomise	 v2.9	 (Winkler	 et	 al.,	 2014)	 with	threshold-free	 cluster	 enhancement	 (TFCE)	 (Smith	 and	 Nichols,	 2009)	 and	 on	the	null	hypothesis	for	each	permutation	that	QSM/R2*	means	are	equal	on	both	young	 and	 elderly	 groups.	 Cluster-based	 inferences	were	made	 through	 5,000	permutations	of	the	data	at	a	family-wise	error	(FWE)	corrected	threshold	level	of	0.05	with	default	TFCE	settings.	Subsequently	after	analysis,	the	QSM	template	and	 study	 results	 were	 warped	 to	 MNI152	 space	 (Montreal	 Neurological	Institute,	 McGill	 University,	 Canada).	 The	 study-wise	 template	 to	 MNI152	transformation	was	 estimated	with	 a	 rigid,	 affine	 plus	 deformable	 b-spline	 co-registration	routine	in	ANTs	(‘antsRegistrationSyN’).				
2.10	Impact	of	spatial	smoothing	on	whole-brain	analyses		It	must	be	noted	that	spatial	smoothing	is	common	practice	prior	to	whole-brain	analyses	 to	 reduce	 both	 the	 deleterious	 effects	 of	 data	 dispersion	 due	 to	misregistration	and	the	overall	number	of	independent	statistical	tests.	QSM	and	R2*	data	were,	thus,	smoothed	by	convolution	with	a	3D-Gaussian	kernel	prior	to	performing	 statistics.	 However,	 since	 this	 type	 of	 analysis	 is	 novel	 using	 QSM	data,	 we	 also	 assessed	 the	 performance	 of	 a	 previously	 proposed	 smoothing-compensation	 strategy	 (Lee	 et	 al.,	 2009).	 The	 procedural	 steps	 were	 the	following:	 (i)	 GM	 and	 WM	 tissue	 segments	 were	 inferred	 from	 native	 T1-weighted	 images	 using	 the	 “unified	 segmentation”	 model	 built	 into	 SPM12	(http://www.fil.ion.ucl.ac.uk/spm/software/spm12)	 with	 default	 settings;	 (ii)	both	segments	were	added	together	resulting	in	a	brain	parenchymal	probability	segment,	which	was	warped	 to	 the	 study-wise	 space,	 thresholded	 at	 Prob>0.5	and	binarised;	(iii)	warped	QSM	and	R2*	maps	were	subsequently	brain-masked;	and	 (iv)	 both	 brain	 masks	 and	 quantitative	 maps	 were	 smoothed	 with	 a	 3D-Gaussian	 kernel;	 finally,	 (v)	 smoothed	 QSM/R2*	 volumes	 were	 (element-wise)	divided	by	their	corresponding	smoothed	brain	mask	resulting	 in	parenchyma-specific,	smoothing-compensated	maps.	Four	examples	(data	for	two	young	and	two	elderly	subjects)	of	unsmoothed	and	smoothed,	warped	QSM	and	R2*	maps	are	 shown	 in	 Inline	 Supplementary	 Fig.	 3.	 Fig.	 2	 illustrates	 the	 impact	 of	 such	procedure	in	comparison	with	direct	Gaussian	blurring.	Thus	in	this	regard	B,	D	and	 F	 correspond	 to	 the	 analyses	 presented	 in	 fig	 5,	 8	 and	 9	 respectively.	Qualitatively,	the	former	appears	to	be	desirable	in	that	significant	clusters	were	overall	 brain-specific,	 yet	 more	 widespread.	 This	 is	 most	 noticeable	 in	 signed	QSM	 and	 R2*	 analyses,	 whereas	 the	 same	 strategy	 on	 absolute	 QSM—partly	devised	to	minimise	the	undesirable	effects	of	CSF	contamination—as	expected,	had	 a	 weaker	 impact.	 During	 this	 step,	 the	 newly	 implemented	 smoothing-compensation	strategy	was	deemed	superior	and	used	in	all	subsequent	analyses	presented.		
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Inline	 Supplementary	 Figure	 3.	Axial	 cuts	 of	 spatially	normalized	QSM	 (left)	and	 R2*	 data	 (right).	 (A-B)	 Global	 mean	 maps.	 (C-D/G-H	 and	 K-L/O-P)	Unsmoothed	maps	for	two	young	and	two	elderly	subjects,	respectively.	(E-F/I-J	and	M-N/Q-R)	Smoothing-compensated	data	for	the	same	subjects.	
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Figure	 2.	 Qualitative	 comparison	 between	 smoothing	 methods.	 (A-B)	 Signed	QSM,	(C-D)	absolute	QSM	and	(E-F)	R2*.	The	left	column	of	each	pair	represents	results	for	elderly	versus	young	comparisons	with	direct	Gaussian	smoothing	(A,	C	and	E);	brain-specific,	smoothing-compensated	results	are	on	the	right	side	(B,	D	and	F).	Abbreviations:	healthy	elderly	(HE),	healthy	young	(HY).			The	relationship	between	smoothing	kernel	width	and	cluster	extent	is	also	yet	unknown	for	QSM	data;	thus,	to	provide	some	insight,	we	qualitatively	compared	results	using	three	Gaussian	kernels	with	standard	deviation	(sigma):	1.5,	3	and	5	 mm	 (Fig.	 3).	 As	 expected,	 blurring	 QSM/R2*	 data	 improved	 both	 cluster	sensitivity	and	spatial	confluence,	 though	the	effect	of	kernel	size	was	different	across	data	type.	For	signed	QSM,	improvements	were	observed	when	increasing	kernel	 width	 from	 1.5-	 to	 3-mm	 sigma,	 but	 a	 wider	 kernel	 appeared	 to	
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excessively	blur	away	 statistical	 effects.	 For	absolute	QSM	data,	we	observed	a	monotonic	 increase	in	cluster	extent	as	a	 function	of	kernel	width;	whereas	for	R2*	data,	a	plateau	effect	was	observed	 for	kernel	widths	of	3	mm	and	greater.	We	concluded	that	a	Gaussian	kernel	width	with	standard	deviation	of	3	mm	was	appropriate	in	the	context	of	this	study.	
	
	
	
	
	
Figure	3.	 Impact	of	varying	Gaussian	smoothing	kernel	widths	for	(A-C)	signed	QSM,	 (D-F)	 absolute	QSM	 and	 (G-I)	 R2*.	 Blue	 clusters	 represent	 significant	 old	versus	young	differences	without	smoothing.	The	left	column	for	each	metric	(A,	D	 and	 G)	 show	 smoothing-compensated	 results	 for	 a	 kernel	 with	 standard	deviation	 (sigma)	 of	 1.5	 mm;	 middle	 columns	 (B,	 E	 and	 H)	 show	 significant	clusters	 applying	 a	 3-mm	 wide	 kernel;	 and	 (C,	 F	 and	 I)	 for	 5-mm	 sigma.	Abbreviations:	healthy	elderly	(HE),	healthy	young	(HY).	
	
	
2.11	Impact	of	global	atrophy	on	whole-brain	analyses	
	Furthermore,	it	is	unknown	whether	the	impact	of	global	brain	atrophy	(e.g.	due	to	co-registration	performance	bias,	which	may	play	a	role	when	contrasting	old	versus	 young	 subjects)	 could	 drive	 QSM/R2*	 whole-brain	 results.	 We	 tested	whether	 this	 could	 be	 true	 in	 two	 steps:	 (i)	 with	 a	 linear	 model	 on	 the	 null	hypothesis	that	QSM/R2*,	for	each	group	separately,	do	not	interact	with	a	global	atrophy	measure	–	estimated	as	total	brain	volume	(sum	of	GM	plus	WM	voxels	with	probability	greater	than	0.5)	adjusted	by	a	measure	of	intracranial	volume	
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(Jack	et	al.,	1989)	determined	using	a	previously	validated	method	(Pengas	et	al.,	2009);	then	if	(i)	cannot	be	rejected,	(ii)	with	a	second	linear	model	formulated	on	 the	 null	 hypothesis	 that	 QSM/R2*	 group	 differences	 cannot	 be	 globally	explained	by	adjusted	brain	volumes.	Negative	results	(i.e.	insufficient	statistical	significance	 to	 reject	 any	 of	 the	 two	 hypotheses)	 across	 the	 whole	 brain	confirmed	that	with	the	proposed	methodology	age-related	QSM/R2*	effects	are	largely	independent	of	global	atrophy.				
2.12	QSM	dependence	on	head	orientation	and	sex		QSM	 estimations	 in	 a	 uniaxial	 environment	 such	 as	 WM	 are	 known	 to	 be	orientation-dependent	 (Liu,	 2010).	 We	 calculated	 the	 angle	 of	 the	 anterior	commissure/posterior	 commissure	 line	 with	 respect	 to	 the	 axial	 plane	perpendicular	 to	 the	 main	 magnetic	 field	 for	 each	 subject,	 and	 found	 a	 slight	head	angulation	difference	between	groups	(αy=3.3±3.2°,	αe=7.0±5.0°;	two-tailed	Wilcoxon	rank-sum	test	of	equal	medians:	Z=-2.9,	p=0.008).	We,	therefore,	tested	whether	QSM	data	dispersion	 in	older	adults	 could	be	explained	by	 systematic	differences	 in	 head	 orientation	 by	 way	 of	 a	 two-group	 comparison	 using	 an	analogous	 permutation-based	 framework	 as	 described	 in	 section	 2.11,	 only	 in	this	 instance,	 adding	 head	 orientation	 as	 a	 variable	 of	 interest	 to	 the	 design	matrix.	As	with	atrophy,	we	found	no	evidence	supporting	this	prediction.	It	was	concluded,	 therefore,	 that	 although	 it	 is	 important	 to	 continue	 challenging	 the	impact	of	systematic	differences	in	brain	angulation,	this	would	need	to	be	large	in	absolute	terms	(>>5±5°)	to	induce	a	non-negligible	QSM	dependency.		Using	the	same	strategy,	only	with	sex	as	the	variable	of	interest,	we	also	tested	whether	whole-brain	QSM/R2*	effects	in	young	and	older	adults	were	different	between	males	and	females	but	neither	null	hypothesis	(sex	interaction	or	main	effect)	 could	 be	 rejected,	 which	 is	 consistent	 with	 our	 previous	 3T	 results	showing	 negligible	 effects	 in	most	 subcortical	 structures	 (Acosta-Cabronero	 et	al.,	2016).		
	
2.13	Regional	QSM	and	R2*	analyses		For	ROI	analyses,	median	values	of	unsmoothed	signed	QSM,	absolute	QSM	and	R2*	values	were	extracted	bilaterally	from	the	caudate	nucleus,	putamen,	globus	pallidus	 (GP),	 hippocampus,	 amygdala	 and	 thalamus	 automatically	 using	 the	FIRST	algorithm	(Patenaude	et	al.,	2011)	on	 the	anatomical	T1	 template	 image.	An	 additional	 six	 subcortical	 ROIs,	 namely	 the	 red	 nucleus	 (RN),	 subthalamic	nucleus	 (STN),	 substantia	 nigra	 (SN),	 cerebellar	 dentate	 nucleus	 (DN)	 and	internal	 (GPi)	 and	 external	 pallidum	 (GPe)	 were	manually	 traced	 on	 the	 QSM	template.	In	order	to	reduce	edge	effects,	all	deep	brain	ROIs	were	eroded	in	3D	by	convolution	with	a	1-mm	radius	spherical	kernel.		Median	values	were	also	calculated	from	cortical	ROIs	inferred	from	the	Desikan-Killiany-Tourville	 (DKT)	 atlas	 (Klein	 and	 Tourville,	 2012).	 The	 OASIS-30	template	and	OASIS-TRT-20	joint	fusion	atlas	(in	OASIS-30	space)	were	obtained	
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from	 Mindboggle’s	 repository	 (http://www.mindboggle.info/data).	 The	 study-wise	to	OASIS-30	space	nonlinear	warp	field	was	calculated	with	a	deformable	b-spline	co-registration	routine	 in	ANTs	(‘antsRegistrationSyN’).	DKT	 labels	were	brought	 into	 the	 study	 space	 using	 the	 inverse	 of	 such	 transformation	 and	nearest-neighbour	 interpolation.	 Finally,	 to	 minimise	 partial-volume	contamination	and	co-registration	errors,	each	cortical	ROI	was	intersected	with	a	study-wise	GM	mask	–	the	warped,	population-average	GM	segment	binarised	at	a	probability	cut-off	of	0.5.			ROIs	in	WM	were	similarly	inferred	from	Johns	Hopkins’	ICBM-DTI-81	WM	atlas	(Mori	 et	 al.,	 2008).	 Warped	 (to	 study	 space	 with	 ANTs)	 ROI	 labels	 were	intersected	by	a	population-average	WM	mask	and	the	complement	mask	of	all	cortical	and	subcortical	ROIs.		See	Fig.	4	for	summary	of	all	selected	regions.			
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Figure	 4.	 Summary	 of	 all	 segmented	 regions	 of	 interest.	 In	 panel	 (A)	 caudate	nucleus	 (red),	 putamen	 (green),	 globus	 pallidus	 (GP;	 yellow)	 thalamus	 (blue),	hippocampus	 (turquoise)	 and	 amygdala	 (copper)	 were	 segmented	 bilaterally	from	the	anatomical	T1	template	using	FSL	FIRST	(Patenaude	et	al.,	2011).	In	(B),	the	 internal	 globus	pallidus	 (GPi;	 brown),	 external	 globus	pallidus	 (GPe;	pink),	dentate	 nucleus	 (DN;	 green)	 subthalamic	 nucleus	 (STN;	 red),	 substantia	 nigra	(SN;	blue)	and	red	nucleus	(yellow)	were	all	segmented	manually	from	the	QSM	template.	 In	 panel	 (C),	 example	 cortical	 ROIs	 inferred	 from	 the	 DKT	 atlas	segmented	 from	 the	 study-wise	 T1	 template.	 In	 panel	 (D),	 example	 WM	 ROIs	similarly	inferred	from	the	ICBM-DTI-81	white	matter	atlas.		
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2.14	Validity	and	reliability	of	template	based	extractions		In	order	to	assess	the	validity	of	extracting	quantitative	information	from	small	structural	regions	directly	in	template	space,	absolute	QSM,	signed	QSM	and	R2*	data	from	each	subject’s	native	DN,	RN,	SN	and	STN	were	manually	extracted	and	compared	 to	 those	 inferred	 from	a	single	ROI	 traced	 in	 template	space.	Single-measure,	 intra-class	 correlation	 coefficients	 (ICC)	 +/-	 the	 95%	 confidence	interval	 (lower/upper	 bounds),	 taking	 the	 ROI	 as	 class	 and	 correlating	 across	extraction	 methods,	 demonstrated	 overall	 that	 the	 proposed	 template	 based	approach	achieved	high	accuracy	when	compared	to	manually	delineating	ROIs	in	native	space	(see	Table	1).	The	exceptions	were	DN,	SN	and	STN	extractions	using	signed	and	absolute	QSM	data,	which	were	clearly	influenced	by	their	wide	implicit	 data	 dispersion	 (see	 Table	 2);	 in	 contrast,	 it	 must	 be	 noted	 R2*	extractions	from	DN	and	STN	were	in	greater	agreement.			For	 completeness,	 single-measure	 ICCs	 were	 also	 performed	 in	 regions	segmented	automatically	using	the	FIRST	algorithm.	Taking	the	ROI	as	class	and	correlating	 across	methods	 (T1	 native	 space	 vs	 template-based),	 ICC	 and	 95%	confidence	 intervals	 for	caudate	nucleus,	putamen,	GP,	hippocampus,	amygdala	and	 thalamus	using	 absolute	QSM,	 signed	QSM	and	R2*	 values	were	 generated	(see	Table	1).	Overall,	template	derived	values	were	in	excellent	agreement	with	native	 extractions	 using	 FIRST.	 Signed	 QSM	 values	 demonstrated	 the	 greatest	variability,	 however	 absolute	 QSM	 and	 R2*	 ICCs	 for	 all	 ROIs	 were	 highly	concordant.				
																															 DN	 RN	 SN	 STN	 	 Caud	 Put	 GP	 Hippo	 Amyg	 Thal	
ICC		(95%)		
QSM	
signed	 0.58	(0.12-	0.80)	 0.96	(0.92-	0.98)	 0.64		(0.20-	0.83)	 0.38	(0.09-0.61)	 	 	 0.98	(0.97-	0.99)	 0.99	(0.99-	1.0)	 0.71	(0.52-	0.84)	 0.93	(0.87-	0.96)	 0.84	(0.72-	0.91)	 0.89	(0.80-	0.94)	
|QSM|	 0.63	(0.14-0.83)	 0.96		(0.91-0.98)	 0.82	(0.68-0.90)	 0.38	(0.09-	0.61)	 	 	 0.98	(0.97-	0.99)	 0.99	(0.99-	0.99)	 0.87	(0.76-	0.93)	 0.97	(0.94-	0.98)		 0.98	(0.96-	0.99)	 0.99	(0.98-	1.0)	
	 R2*	 0.85	(0.73-	0.92)	 0.86	(0.75-	0.92)	 0.65	(0.43-	0.80)	 0.73	(0.55-	0.85)	 	 	 0.99	(0.97-	1.0)	 1.0	 0.91	(0.83-	0.95)	 0.98	(0.97-	0.99)	 0.98	(0.95-	0.99)	 0.99	(0.99-	1.0)		
	
Table	 1.	Validity	measures	 for	 template	based	ROI	extractions.	Single-measure	ICC	 +/-	 the	 95%	 confidence	 interval	 (lower/upper	 bounds),	 taking	 the	 ROI	 as	class	 and	 correlating	 across	 methods	 (native	 vs	 template-derived	 values)	 for	manual	 (displayed	 on	 left)	 and	 automatically	 (displayed	 on	 right)	 segmented	ROIs.	 Abbreviations:	 region	 of	 interest	 (ROI),	 intra-class	 correlation	 coefficient	(ICC),	 absolute	 QSM	 (|QSM|),	 red	 nucleus	 (RN),	 substantia	 nigra	 (SN),	subthalamic	 nucleus	 (STN),	 caudate	 nucleus	 (Caud),	 putamen	 (Put),	 globus	pallidus	(GP),	hippocampus	(Hippo),	thalamus	(Thal),	dentate	nucleus	(DN).			Test-retest	reliability	of	absolute	QSM,	signed	QSM	and	R2*	data	extracted	from	SN,	 RN	 and	 DN	 ROIs	 traced	 by	 two	 different	 raters	 (M.B.	 and	 J.A-C.)	 was	 also	evaluated	using	a	single-measure	ICC.	For	QSM	extractions	from	SN,	RN	and	DN,	ICC	+/-	 the	95%	confidence	 interval,	were	0.97	 (0.95–0.99),	0.99	 (0.99	–	1.00)	
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and	0.94	(0.89–0.97)	respectively.	For	R2*,	SN,	RN	and	DN	extractions,	 ICC	and	95%	confidence	were	0.99	(0.98–0.99),	0.98	(0.97	–	0.99)	and	0.94	(0.88–0.97),	respectively,	 demonstrating	 that	 the	 proposed	 template-based	 ROI	 extraction	approach	is	highly	reproducible.			
2.15	Regional	inter-hemispheric	differences		Inter-hemispheric	differences	in	absolute	QSM,	signed	QSM	and	R2*	were	probed	using	 Wilcoxon	 rank-sum	 tests,	 which	 revealed	 that	 left/right	 measurements	were	 consistent	 across	 the	 whole	 brain	 (p>0.05).	 In	 order	 to	 improve	measurement	 stability,	 thus,	 median	 ROI	 values	 were	 averaged	 across	hemispheres	prior	to	computing	old-versus-young	Wilcoxon	rank-sum	statistics.	In	 addition,	 to	 correct	 for	 the	 effect	 of	 multiple	 comparisons	 a	 statistical	threshold	of	p<0.004	was	set	throughout	(i.e.	Bonferroni-corrected	p<0.05	for	12	tests).	All	tests	were	performed	two-tailed.			
2.16	Effect-size	calculation		Z’	 scores	 were	 computed	 to	 compare	 the	 sensitivity	 of	 QSM	 and	 R2*	measurements	in	each	ROI.	A	Z’	score—acting	as	a	measure	of	effect	size—was	defined	as	the	group	mean	difference	relative	to	the	global	standard	deviation:		 𝑍′ = !!!!!!!!!! 	,																																																													(1)		where	μe	represents	the	global	mean	across	the	elderly	group,	μy	is	the	mean	of	the	 young	 control	 group,	 σe	is	 the	 standard	 deviation	 across	 the	 elderly	 group	and	σy	is	the	standard	deviation	across	the	young	control	group.		
	
2.17	Computational	framework		All	data	postprocessing	was	performed	on	a	desktop	computer	with	two,	3.1-GHz	octa-core	 hyper-threading	 CPUs,	 64	 GB	DDR3	RAM	 and	 four	 solid-state	 drives	operated	 by	 Ubuntu	 Linux	 12.04.	 All	 processing	 tasks	 (including	 QSM	reconstruction	 and	 regional	 data	 extraction)	 unless	 stated	 otherwise	 were	performed	 in	 the	MATLAB	 environment	 (R2012a;	 The	Mathworks	 Inc.,	 Natick,	MA,	 USA).	 Finally,	 ROI	 statistical	 tests	 were	 performed	 using	 the	 Statistical	Package	for	the	Social	Sciences	(SPSS),	version	22.0.	
	
3.	RESULTS		
3.1	Age-related	differences	in	whole-brain	QSM	maps	
	Two-sample	 (elderly	 greater	 than	 young)	 permutation	 testing	 (PFWE<0.05)	 on	signed	susceptibility	maps	(QSM)	revealed	significant	age-related	differences	in	several	 subcortical	 and	 cortical	 regions	 (Fig.	 5).	 Within	 deep	 brain	 nuclei,	extensive	bilateral	clusters	were	observed	at	the	sites	of	the	caudate	nucleus	and	putamen	(collectively	referred	to	as	the	striatum),	mesencephalon	(RN	and	SN),	diencephalon	 (STN,	 mammillary	 bodies	 and	 thalamus)	 and	 cerebellar	 DN.	 In	
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cortical	 GM,	 clusters	 of	 statistical	 significance	 were	 confluent	 and	 bilateral	 in	superior	 frontal	 areas,	 namely	 the	 premotor	 cortex,	 primary	motor	 cortex	 and	supplementary	 motor	 area	 passing	 into	 the	 dorsal	 medial	 prefrontal	 cortex	(PFC)	 and	 insula.	 More	 patchy	 alterations	 were	 observed	 in	 parietal	 cortices,	lateral	 occipital	 areas,	 inferior	 frontal	 gyrus,	 ventral	 PFC	 and	 brainstem.	 Age-related	 QSM	 differences	 in	 WM	 were	 overall	 less	 extensive,	 although	 a	 large	cluster	was	identified	in	posterior	parietal	WM	at	the	site	of	the	optic	radiation.	In	all	cases,	non-normalised	signed	QSM	values	are	presented	throughout.		
	
	
	
Figure	 5.	 Whole-brain	 age-related	 distribution	 of	 increased	 signed	 QSM.	Thresholded	 (PFWE<0.05)	 statistical	 map	 for	 the	 cluster-wise	 comparison	between	 N=20	 older	 and	 N=20	 younger	 adults	 using	 non-normalised	 QSM	values.	Results	were	standardized	to	MNI152	space	and	overlaid	onto	the	MNI-
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warped	 mean	 QSM	 template	 (N=40).	 Abbreviations:	 healthy	 elderly	 (HE),	healthy	young	(HY).		The	opposite	contrast	(i.e.	signed	QSM	reductions	in	older	adults)	also	revealed	widespread	 alterations	 but	 mostly	 in	 WM	 (Fig.	 6).	 Notably,	 large	 bilateral	clusters	 were	 identified	 in	 internal	 and	 external	 capsule,	 corpus	 callosum,	prefrontal,	 temporal,	 cerebellar	 and	 pontine	 WM.	 In	 several	 areas,	 however,	significant	 clusters	 also	 extended	 across	 GM	 regions	 e.g.	 cingulate,	 thalamus,	occipital	and	cerebellar	cortex	bilaterally.			
	
	
	
Figure	 6.	 Whole-brain	 age-related	 distribution	 of	 signed	 QSM	 reductions.	Thresholded	 (PFWE<0.05)	 statistical	 map	 for	 the	 cluster-wise	 comparison	between	 older	 and	 younger	 adults	 using	 non-normalised	 QSM	 values.	 Results	were	 standardized	 to	MNI152	 space	 and	 overlaid	 onto	 the	warped	mean	QSM	
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template.	Abbreviations:	healthy	elderly	(HE),	healthy	young	(HY).			Fig.	 7	 illustrates	 the	 whole-brain	 results	 for	 increased	 positive-only	 QSM	 and	reduced	negative-only	QSM	in	older	adults,	both	of	which	are	highly	consistent	with	results	 from	positive	(increased	 in	older	adults)	and	negative	(decreased)	contrasts	using	signed	QSM	data	(Fig.	5	and	6,	respectively).	Slightly	differential	effects,	 however,	 were	 observed	 for	 increased	 positive-QSM	 (relative	 to	increased	signed	QSM),	where	more	patchy	behaviour	was	observed	 in	ventral	prefrontal	and	occipital	areas,	whereas	more	extensive	clusters	were	 identified	in	 the	 right	 temporal	 lobe.	The	opposite	 contrasts	 (i.e.	 decreased	positive-QSM	and	 increased	 negative-QSM	 in	 older	 adults)	 did	 not	 reveal	 any	 statistically	significant	 difference	 at	 the	 corrected	 threshold	 level	 used	 throughout	 the	present	study	(PFWE<0.05).			
	
	
Figure	7.	Whole-brain	distribution	of	age-related	(A)	greater	positive-only	QSM	
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and	 (B)	 reduced	 negative-only	 QSM.	 Thresholded	 (PFWE<0.05)	 statistical	 maps	for	 the	 cluster-wise	 comparison	 between	 older	 and	 younger	 adults	 using	 non-normalised	 QSM	 values.	 Results	 were	 standardized	 to	 MNI152	 space	 and	overlaid	 onto	 the	 warped	 mean	 QSM	 template.	 Abbreviations:	 healthy	 elderly	(HE),	healthy	young	(HY).			Whole-brain	 results	 for	 increased	absolute	QSM	 in	older	adults—shown	 in	Fig.	8—were	 also	 highly	 consistent	 with	 those	 for	 signed	 QSM.	 As	 a	 composite	 of	positive	 and	 negative	 effects,	 however,	 clusters	 in	 Fig.	 8	 extended	 across	subcortical	 structures	 and	 dorsal	 prefrontal,	 temporal	 and	 cerebellar	 areas,	primarily	 in	 the	 cortex	 but	 also	 in	 WM.	 As	 with	 signed	 QSM,	 non-normalised	absolute	 QSM	 values	 are	 presented	 throughout.	 Interestingly,	 results	 for	absolute	QSM	were	also	less	extensive	in	ventral	prefrontal,	inferior	parietal	and	occipital	 areas	 than	 increased	 signed	 QSM	 in	 older	 adults;	 whereas	 stronger	effects	 were	 observed	 in	 right	 temporal	 areas	 including	 hippocampus	 and	amygdala.	The	opposite	contrast	(i.e.	age-related	decreases	in	absolute	QSM)	did	not	return	any	statistically	significant	difference.			
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Figure	 8.	Whole-brain	 distribution	 of	 age-related	 increases	 in	 absolute	 QSM.	Thresholded	 (PFWE<0.05)	 statistical	 map	 for	 the	 cluster-wise	 comparison	between	 older	 and	 younger	 adults	 using	 non-normalised	 QSM	 values.	 Results	were	 standardized	 to	MNI152	 space	 and	 overlaid	 onto	 the	warped	mean	QSM	template.	Abbreviations:	healthy	elderly	(HE),	healthy	young	(HY).			
3.2	Age-related	differences	in	whole-brain	R2*	maps	
	R2*	 thresholded	 (PFWE<0.05)	 statistical	maps	 (elderly	 greater	 than	 young)	 also	revealed	strong	age-related	differences	in	many	cortical	and	subcortical	regions	(Fig.	 9).	 Within	 deep	 brain	 nuclei,	 confluent	 bilateral	 distributions	 were	observed	 in	 the	 striatum,	 GP,	 midbrain,	 STN,	 medulla	 oblongata	 and	 DN.	Predominantly	unilateral	 effects	were	also	observed	 in	 the	 right	 amygdala	and	
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hippocampus.	No	such	effects	were	observed	in	the	thalamus,	with	the	exception	of	 the	 pulvinar.	 In	 the	 cortex,	 confluent	 and	 bilateral	 R2*	 increases	 were	observed	 in	 occipital,	 parietal,	 temporal,	 superior	 prefrontal,	 insular	(predominantly	 posterior)	 and	 cerebellar	 regions.	 In	 contrast	 to	 the	 QSM	distribution,	age-related	differences	were	chiefly	restricted	to	GM.	The	opposite	contrast	(i.e.	age-related	R2*	reduction)	was	completely	negative.	
	
	
	
	
Figure	9.	Whole-brain	distribution	of	age-related	increases	in	R2*.	Thresholded	(PFWE<0.05)	statistical	map	for	the	cluster-enhanced	comparison	between	older	and	 younger	 adults.	 Results	 were	 standardized	 to	MNI152	 space	 and	 overlaid	onto	the	warped	mean	R2*	template.	Abbreviations:	healthy	elderly	(HE),	healthy	young	(HY).	
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3.3	Deep	brain	regional	analysis	using	QSM	and	R2*		The	 deep	 brain	 ROI	 analysis	 confirmed	 significant	 age-related	 absolute	 QSM	increases	in	the	RN,	caudate	nucleus,	putamen	and	thalamus	(Fig.	10A;	rank-sum	tests	all	p<0.0001),	SN	and	hippocampus	(p<0.001),	STN	and	DN	(both	p<0.05,	Bonferroni-corrected	for	12	tests).	An	age-related	increase	was	also	observed	in	the	amygdala	but	it	did	not	survive	Bonferroni	correction.	No	significant	effects	were	observed	in	the	GP,	or	its	GPi	and	GPe	sub-regions	(see	Table	2).				
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Figure	 10.	Regional	 summary	 statistics	 for	 subcortical	ROIs.	 (A)	Mean	±	S.E.M	for	 absolute	 susceptibility	 maps	 (in	 parts	 per	 million),	 (B)	 for	 signed	susceptibility	(ppm),	and	(C)	for	R2*	(s-1)	in	major	deep	brain	nuclei	of	young	and	older	 adults.	 Non-normalised	 QSM	 values	 are	 reported	 throughout.	Abbreviations:	 red	 nucleus	 (RN),	 substantia	 nigra	 (SN),	 subthalamic	 nucleus	(STN),	 external	 globus	 pallidus	 (GPe),	 internal	 globus	 pallidus	 (GPi),	hippocampus	(Hippo),	thalamus	(Thal),	dentate	nucleus	(DN).	***	(p<0.0001),	**	(p<0.001),	 *	 (p<0.004;	 Bonferroni-corrected	 p<0.05	 for	 12	 tests),	 indicate	significant	difference	in	old	compared	to	younger	adults	(Wilcoxon	ranked-sum	tests).		For	 signed	QSM	 values,	 significant	 age-related	 differences	 in	 the	RN,	 putamen,	thalamus	 (Fig.	 10B;	 rank-sum	 tests	 all	 p<0.0001),	 SN,	 caudate	 (p<0.001),	 STN	and	DN	(both	p<0.05,	Bonferroni-corrected	for	12	tests)	were	observed	in	older	adults.		The	R2*	ROI	analysis	found	significant	age-related	increases	in	the	RN,	SN,	STN,	caudate	 nucleus,	 putamen,	 GP	 localized	 to	 the	 external	 segment	 (GPe),	hippocampus	 (all	 p<0.0001),	 amygdala	 and	 DN	 (p<0.05,	 Bonferroni-corrected	for	12	tests).	No	significant	effects	were	observed	in	the	GPi	and	thalamus	(Fig.	10C;	 Table	 2).	 Furthermore,	 male-versus-female	 group	 comparisons	 for	 both	QSM	and	R2*	values	were	negative	in	all	deep	brain	regions	of	interest	(rank-sum	test;	p>0.05;	Bonferroni-corrected	for	12	tests). 		Significant	effect-size	differences	 (absolute	QSM	>	signed	QSM)	were	 identified	(Wilcoxon	 signed-ranks	 test;	 p<0.05,	 Bonferroni-corrected	 for	 12	 tests)	 in	 RN,	SN,	caudate,	putamen,	hippocampus	thalamus	and	DN	(all	p	<	0.001,	see	Table	2).	More	 generally,	 in	 all	 ROIs	 (except	 for	 the	 amygdala),	 absolute	 QSM	 returned	both	enhanced	age-related	differences	and	reduced	relative	variance	(as	would	be	 expected	 from	 taking	 the	 absolute	 to	 a	 set	 of	 real	 numbers).	 Comparing	absolute	QSM	with	R2*	Z’	scores	also	revealed	a	significant	increase	in	sensitivity	to	age-related	differences	for	absolute	QSM	in	the	thalamus	and	for	R2*	in	the	GP	(both	in	GPe	and	GPi).	
	 	 	 	
RN	 SN	 STN	 Caud	 Put	 GP	 GPe	 GPi	 Hippo	 Amyg	 Thal	 DN	
Group	
Stats	 Mean		QSM	
signed	
±	SEM		
(ppm)	
HY	 0.068	±		0.0025	 0.080	±	0.0035	 0.033	±	0.0047	 0.030	±	0.0007	 0.014	±	0.0008	 0.073	±	0.0018	 0.078	±	0.0018	 0.080	±	0.0030	 -0.003	±	0.0009	 -0.008	±	0.0016	 -0.0002	±	0.0004	 0.049	±	0.0048	
HE	 0.106	±	0.0067	 0.101	±	0.0035	 0.053	±	0.0012	 0.042	±	0.0023	 0.037	±	0.0022	 0.075	±	0.0024	 0.078	±	0.0024	 0.076	±	0.0029	 -0.003	±	0.0009	 -0.004	±	0.0012	 0.003	±	0.0005	 0.075	±	0.0071		 Rank-sum	
test		 Z	 -3.9	 -3.5	 -2.8	 -3.5	 -5.4	 NA	 NA	 NA	 NA	 NA	 -3.7	 -3.0	
P	 <0.0001	 0.0003	 0.004	 0.0003	 <0.0001	 0.4	 0.7	 0.5	 0.6	 0.2	 <0.0001	0.002		 Mean	|QSM|	±	SEM	(ppm)	 HY	 0.068	±		0.0025	 0.081	±	0.0031	 0.043	±	0.0036	 0.031	±	0.0006	 0.021	±	0.0007	 0.073	±	0.0018	 0.078	±	0.0018	 0.080	±	0.0030	 0.020	±	0.0005	 0.019	±	0.0015	 0.016	±	0.0003	 0.050	±	0.0042	
	
HE	
0.106	±	0.0067	 0.101	±	0.0034	 0.059	±	0.0041	 0.043	±	0.0022	 0.041	±	0.0021	 0.075	±	0.0022	 0.078	±	0.0023	 0.078	±	0.0027	 0.024	±	0.0006	 0.022	±	0.0010	 0.021	±	0.0008	 0.077	±	0.0065		 Rank-sum	test	 Z	 -3.9	 -3.5	 -2.9	 -3.9	 -5.4	 NA	 NA	 NA	 -3.4	 NA	 -4.2	 -3.2		 	 P	 <0.0001	 0.0002	 0.004	 <0.0001	 <0.0001	 0.3	 0.5	 0.5	 0.001	 0.05	 <0.0001	 0.001		 Mean	R2*	
±	SEM		
(s-1)	 HY	 60	±	0.90	 65	±	1.3	 60	±	1.5	 37	±	0.45	 44	±	0.56	 77	±	1.6	 80	±	1.6	 78	±	2.0	 28	±	0.35	 27	±	0.44	37	±	0.34	 53	±	1.8	
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HE	 75	±	2.3	 77	±	1.9	 73	±	2.5	 48	±	1.2	 64	±	1.9	 88	±	1.8	 94	±	2.0	 82	±	1.8	 31	±	0.50	 30	±	1.01	37	±	0.75	 66	±	3.5		 Rank-sum	
test	 Z	 -4.5	 -4.0	 -4.3	 -5.3	 -5.4	 -4.1	 -4.3	 NA	 -4.4	 -3.2	 NA	 -3.1	
P	 <0.0001	 0.0002	 0.0001	 <0.0001	 <0.0001	 0.0002	 <0.0001	 0.06	 0.0001	 0.001	 0.6	 0.002		 Z’-score	
(HE	vs	HY	
effect	
size)		 |QSM|	 0.94++	 0.68++	 0.47	 0.98++	 1.7++	 0.11	 0.02	 -0.14	 0.64++	 0.23	 0.95++	 0.56++	QSM	
	signed	
	
QSM	
	Norm	
0.89			0.77	
0.65			0.55	
0.46			0.35	
0.90			0.94	
1.5			1.4	
0.08			0.03	
0.01			-0.09	
-0.15			-0.05	
-0.05			0.31	
0.30			0.47	
-0.69		
0.34	
0.50			0.54	
R2*	 1.0	 0.77	 0.74	 1.4	 1.8	 0.76	 0.88	 0.25	 0.88	 0.57	 0.007	 0.58	
|QSM|	
vs	R2*	 Signed-	ranks	test	 Z	 NA	 NA	 NA	 NA	 NA	 -3.4	 -3.6	 -2.9	 NA	 NA	 -3.7	 NA	
P	 0.9	 0.8	 0.06	 0.04	 0.7	 0.001	 <0.0001	 0.004	 0.04	 0.006	 <0.0001	 1.0		
Table	 2.	 Summary	 of	 regional	 group	 statistics.	 Abbreviations:	 healthy	 young	(HY),	healthy	elderly	(HE),	red	nucleus	(RN),	substantia	nigra	(SN),	subthalamic	nucleus	 (STN),	 caudate	 nucleus	 (Caud),	 putamen	 (Put),	 globus	 pallidus	 (GP),	external	 globus	 pallidus	 (GPe),	 internal	 globus	 pallidus	 (GPi),	 hippocampus	(Hippo),	 thalamus	 (Thal),	 dentate	 nucleus	 (DN),	 absolute	 QSM	 (|QSM|),	normalised	QSM	(norm),	not	significant	(NS),	not	applicable	(NA).	++	Significant	differences	 between	 absolute	 and	 signed-QSM	 Z’	 scores	 (p<0.001,	 post-hoc	Wilcoxon	ranked-sum	tests).	
	
3.4 Cortical	regional	analysis	using	QSM	and	R2*	
	The	 cortical	 ROI	 analysis	 confirmed	 significant	 age-related	 absolute	 QSM	differences	 in	 fusiform	 (Fus),	 paracentral	 (PC),	 pars	 opercularis	 (POPE),	postcentral	(POC),	posterior	cingulate	(PCC),	precentral	(PREC),	superior	frontal	(SFC),	superior	temporal	(STC),	supramarginal	(SMC)	and	insula	(Ins)	(Fig.	11A;	rank-sum	tests	all	p<0.0001),	caudal	middle	frontal	(CMF)	and	superior	parietal	cortex	 (SPC)	 (both	 p<0.001).	 Using	 signed	 QSM	 values,	 significant	 age-related	differences	were	 observed	 in	 triangularis	 (PTRI)	 and	 PCC	 (Fig.	 11B;	 rank-sum	tests	both	p<0.0001),	PC	and	transverse	temporal	cortex	(TTC)	(both	p<0.001).	For	R2*,	extensive	significant	age-related	differences	in	the	cortex	were	observed	in	cuneus	(Cun),	Fus,	inferior	parietal	(IPC),	lateral	occipital	(LOC),	lingual	(Ling),	middle	temporal	(MTC),	parahippocampal	(PHC),	PC,	pars	orbitalis	(POPE),	PTRI,	pericalcarine	(PCAL),	postcentral	(POC),	PCC,	PREC,	precuneus	(PCUN),	SPC,	STC	and	TTC	(Fig.	11C;	rank-sum	tests	all	p<0.0001),	anterior	cingulate	ACa,	caudal	middle	 frontal	 (CMF),	 isthmus	 cingulate	 (ISTC),	 rostral	middle	 frontal	 (RMFC),	SFC,	SMC	and	Ins	(all	p<0.001).	
	Significant	effect-size	differences	 (absolute	QSM	>	signed	QSM)	were	 identified	in	PCC	and	PREC	 (Wilcoxon	signed-ranks	 test;	p<0.0001),	Fus,	POPE,	POC,	STC	and	 Ins	 (all	 p<0.001),	 ITC	 and	LOC	 (p<0.05,	Bonferroni-corrected	 for	31	 tests)	demonstrating	absolute	QSM	also	returned	greater	age-related	differences	in	the	cortex.	Comparing	absolute	QSM	and	R2*	Z’	scores	revealed	a	significant	increase	in	sensitivity	to	age-related	differences	 for	absolute	QSM	in	Ins.	 In	contrast	R2*	demonstrated	 superior	 sensitivity	 in	 detecting	 age-related	 differences	 in	 Ling	
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and	PCAL.	Overall	 absolute	QSM	and	R2*	 Z’	 scores	 revealed	highly	 comparable	effect	sizes	in	the	cortex	although	significant	differences	in	effect	sizes	(those	for	R2*	greater	than	for	absolute	QSM)	were	found	in	Ling,	PCAL	and	Ins.	
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Figure	 11.	Regional	 summary	 statistics	 for	 cortical	ROIs.	 (A)	Mean	±	S.E.M	 for	absolute	susceptibility	maps	(in	parts	per	million),	 (B)	 for	signed	susceptibility	(ppm),	 and	 (C)	 for	R2*	 (s-1)	 in	 cortical	 regions	of	 young	and	older	adults.	Non-normalised	QSM	values	are	reported	throughout.	Abbreviations:	caudal	anterior	cingulate	 (ACa),	 caudal	middle	 frontal	 (CMF),	 cuneus	 (CUN),	 entorhinal	 (ENT),	fusiform	 (Fus),	 inferior	 parietal	 (IPC),	 inferior	 temporal	 cortex	 (ITC),	 isthmus	cingulate	 (ISTC),	 lateral	 occipital	 (LOC),	 lateral	 orbitofrontal	 (LOF),	 lingual	(Ling),	 medial	 orbitofrontal	 (MOF),	 middle	 temporal	 (MTC),	 parahippocampal	(PHC),	 paracentral	 (PC),	 pars	 opercularis	 (POPE),	 pars	 orbitalis	 (PORB),	triangularis	(PTRI),	pericalcarine	(PCAL),	postcentral	(POC),	posterior	cingulate	(PCC),	 precentral	 (PREC),	 precuneus	 (PCUN),	 rostral	 anterior	 cingulate	 (rACC),	rostral	 middle	 frontal	 (RMFC),	 superior	 frontal	 (SFC),	 superior	 parietal	 (SPC),	superior	 temporal	 (STC),	 supramarginal	 (SMC),	 transverse	 temporal	 (TTC),	insula	 (Ins).	 ***	 (p<0.0001),	 **	 (p<0.001)	 indicate	 significant	 difference	 in	 old	compared	to	younger	adults	(Wilcoxon	ranked-sum	tests).				
3.5 White	matter	regional	analysis	using	QSM	and	R2*	
	The	WM	ROI	analysis	confirmed	significant	age-related	absolute	QSM	differences	in	anterior	limb	of	internal	capsule	(ALIC),	posterior	limb	of	the	interior	capsule	(PLIC),	 posterior	 thalamic	 radiation	 (PTR)	 and	 superior	 longitudinal	 fasciculus	(SLF)	(Fig.	12A;	rank-sum	tests	all	p<0.0001),	superior	corona	radiate	(SCR)	and	external	capsule	(EC)	(both	p<0.001),	body	of	corpus	callosum	(CC-B)	and	fornix	(cres)/stria	 terminalis	 (FX/ST)	 (p<0.002;	 Bonferroni-corrected	 p<0.05	 for	 26	tests).	 Using	 signed	 QSM	 values,	 significant	 age-related	 differences	 were	observed	 in	 ALIC,	 PLIC,	 PTR,	 superior	 fronto-occipital	 fasciculus	 (FOF)	 and	tapetum	 (TAP)	 (Fig.	 12B;	 rank-sum	 tests	 all	 p<0.0001),	 CC-B	 (p<0.001),	 SLF	(Bonferroni-corrected	p<0.05).	For	R2*,	significant	age-related	differences	were	observed	in	fornix	(Fx-B)	(Fig.	12C;	rank-sum	tests;	p<0.0001),	middle	cerebellar	peduncle	 (MCP)	 (p<0.001)	 and	 cerebral	 peduncle	 (CP)	 (Bonferroni-corrected	p<0.05).	
	Significant	effect-size	differences	(signed	QSM	vs	absolute	QSM)	were	identified	in	 ALIC	 and	 SLF	 (Wilcoxon	 signed-ranks	 test;	 p<0.0001),	 CC-B,	 PLIC,	 PTR,	 EC,	FX/ST,	 FOF	 (all	 p<0.001)	 and	 SCR	 (Bonferroni-corrected	 p<0.05).	 Comparing	signed	 QSM	with	 R2*	 Z’	 scores	 revealed	 a	 significant	 increase	 in	 sensitivity	 to	age-related	 differences	 for	 signed	 QSM	 in	 MCP,	 CC-B,	 splenium	 of	 corpus	callosum	 (CC-Sp),	 inferior	 cerebellar	 peduncle	 (ICP),	 CP,	 ALIC,	 PLIC,	 anterior	corona	 radiata	 (ACR),	 posterior	 thalamic	 radiation	 (PTR),	 FX/ST,	 SLF,	 FOF	and	TAP.	 On	 the	 contrary,	 QSM	 absolute	 and	 R2*	 Z’	 scores	 in	 general	 were	 highly	comparable	 although	 significant	 differences	 in	 effect	 sizes	were	 found	 in	 FX-B,	PLIC,	 SLF	 and	 TAP.	 Overall,	 however,	 these	 findings	 demonstrate	 age-related	differences	in	WM	are	greater	with	signed	QSM.			
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Figure	 12.	 Regional	 summary	 statistics	 for	 WM	 ROIs.	 (A)	 Mean	 ±	 S.E.M	 for	absolute	susceptibility	maps	(in	parts	per	million),	 (B)	 for	signed	susceptibility	(ppm),	 and	 (C)	 for	 R2*	 (s-1)	 in	 WM	 regions	 of	 young	 and	 older	 adults.	 Non-normalised	 QSM	 values	 are	 reported	 throughout.	 Abbreviations:	 middle	
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cerebellar	 peduncle	 (MCP),	 pontine	 crossing	 tract	 (PCT),	 genu	 of	 corpus	callosum	(CCg),	body	corpus	callosum	(CC-B),	splenium	of	corpus	callosum	(CC-Sp),	 fornix	 (Fx-B),	 corticospinal	 tract	 (CST),	 medial	 lemniscus	 (ML),	 inferior	cerebellar	peduncle	(ICP),	superior	cerebellar	peduncle	(SCP),	cerebral	peduncle	(CP),	anterior	limb	of	internal	capsule	(ALIC),	posterior	limb	of	internal	capsule	(PLIC),	 retrolenticular	 part	 of	 internal	 capsule	 (RLIC),	 anterior	 corona	 radiata	(ACR),	superior	corona	radiata	(SCR),	posterior	corona	radiata	(PCR),	posterior	thalamic	radiation	(PTR),	sagittal	stratum	(SS),	external	capsule	(EC),	cingulum	(Cg),	 fornix	 (cres)/stria	 terminalis	 (FX/ST),	 superior	 longitudinal	 fasciculus	(SLF),	 superior	 fronto-occipital	 fasciculus	 (FOF),	 uncinate	 fasciculus	 (UF),	tapetum	 (TAP).	 ***	 (p<0.0001),	 **	 (p<0.001),	 *	 (p<0.002;	Bonferroni-corrected	p<0.05	 for	26	tests),	 indicate	significant	difference	 in	old	compared	to	younger	adults	(Wilcoxon	ranked-sum	tests).			
	
4.	DISCUSSION		This	 in	vivo	7T	MRI	study	demonstrated	a	novel	application	using	whole	brain	methods	 to	 characterise	 the	 human	 aging	 process	 using	 both	 QSM	 and	 R2*	measurements.	 This	 is	 the	 first	 account	 to	 our	 knowledge	 to	 directly	 compare	intra-subject	 QSM	 sensitivity	 with	 respect	 to	 R2*	 using	 the	 same	 multi-GRE	sequence.	QSM	revealed	strong	bilateral	age-related	differences	(increased	QSM	values	 in	older	adults)	 in	deep	brain	nuclei,	namely	putamen,	 caudate	nucleus,	thalamus,	STN,	RN,	SN,	hippocampus	and	DN.	Age-related	QSM	alterations	were	also	present	 in	 the	cortex,	particularly	 in	superior	motor	areas,	 lateral	parietal,	insular,	 superior	 temporal	 and	 cerebellar	 cortices.	 Furthermore,	 WM	differences—generally	 age-related	 QSM	 reductions	 but	 also	 an	 increase	 at	 the	site	 of	 the	 posterior	 thalamic	 radiation—were	 also	 identified.	 Importantly,	 we	found	 that	 age-related	 differences	 in	 R2*	 measurements	 were	 more	 apparent	than	with	QSM	in	GM	in	a	distribution	that	also	included	the	GP	and	most	of	the	occipital	 cortex.	 In	 WM,	 R2*	 abnormalities	 were	 restricted	 to	 the	 fornix	 and	midbrain	peduncles;	thus,	they	were	less	widespread	than	QSM	alterations.		In	this	study,	we	have	proposed	an	additional	magnetic	susceptibility	metric	for	the	study	of	brain	mineralisation,	namely	absolute	QSM.	This	metric	couples	both	(i)	increases	in	positive-valued	QSM	and	(ii)	negative-valued	QSM	reductions	in	a	single	 coherent	 effect;	 that	 is,	 aggregating	 non-local	 contributions	 from	 metal	(e.g.	paramagnetic	 iron)	and	alkaline/lipid	species	 (e.g.	diamagnetic	 calcium	or	myelin)	into	a	single	measure.	It	may	seem	counterintuitive	to	conglomerate	two	distinguishable	 effects	 into	 one	 measurement,	 but	 the	 practical	 benefits	 are	relevant	 in	 that	 overall,	 absolute	 QSM	 improves	 statistical	 conditioning.	 This	must	 be	 contextualised	 in	 a	 scenario	 where	 registration	 algorithms	 are	imperfect,	 that	 such	 imperfections	 are	 more	 marked	 in	 the	 cortex	 due	 to	 its	complex	 topology	 with	 some	 cortical	 areas	 being	 more	 prone	 to	 registration	errors	than	others	(Pereira	et	al.,	2010).	If,	in	such	a	scenario,	the	data	type	being	warped	(i.e.	signed	QSM)	is	also	highly	volatile,	i.e.	changing	sign	at	a	high	spatial	frequency,	both	factors,	together,	may	result	in	unphysical	high	variances	(Fig.	1)	–	 a	 detrimental	 effect	 for	 quantitative	 analyses.	 In	 addition,	 in	 ROIs	 showing	complex	 mineralization	 (e.g.	 simultaneous	 brain	 iron	 accumulation	 and	calcification)	 or	 heterogeneous	 composition	 (e.g.	 susceptibility	 in	 some	
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subregions	 dominated	 by	 lipid-rich	 myelin	 and	 by	 iron-rich	 cells	 in	 another),	absolute	 QSM	 can	 partly	 compensate	 for	 the	 counteracting	 effect	 in	 regional	statistics	of	opposing	susceptibility	behaviours,	thus,	it	can	return	greater	effect	sizes	(Fig.	10	and	Table	2);	this	might	be	crucial	for	the	study	of	brain	diseases	where	 it	might	be	desirable	to	 identify	an	effect	 first,	 then	explore	the	possible	origins	of	such	phenomenon.		Another	general	observation	on	signed	QSM	 is	 that,	with	 few	exceptions,	areas	presenting	 an	 age-related	 increase	 in	 QSM	 (Fig.	 5)	 stem	 from	 paramagnetic	(QSM>0)	behaviours	(Fig.	7A),	whereas	the	opposite	behaviour	(decreased	QSM,	Fig.	 9)	 appears	 to	 emanate	 from	 predominantly	 diamagnetic	 (QSM<0)	 tissue	such	 as	WM	 (Fig.	 7B).	 Generally,	 it	 could	 be	 argued	 that	 the	 latter	might	 be	 a	consequence	 of	 the	 former	 due	 to	 blooming	 or	 streaking	 artefacts	 spuriously	rendering	 negative	 QSM	 values	 increasingly	 negative;	 however,	 we	 cannot	 yet	rule	 out	 that	 some	 effects	 might	 be	 real.	 Future	 investigations—with	 ever-improving	 QSM	 inversion	 strategies—might	 shed	 light	 into	 this	 poorly	understood	 behaviour.	 Until	 then,	 studying	 in	 combination	 both	 tails	 of	 the	signed	QSM	distribution	and	the	absolute	value	appears	to	be	helpful	to	capture	the	full	extent	of	QSM-derived	effects.		It	is	noteworthy	that	the	regional	QSM	results	in	deep	brain	nuclei	were	strongly	concordant	 with	 the	 whole-brain	 analysis	 in	 that	 RN,	 SN,	 putamen,	 caudate	nucleus,	 thalamus,	 STN,	 hippocampus	 and	 DN	 (in	 decreasing	 order	 of	significance)	 demonstrated	 the	 strongest	 age-related	 differences	 (Fig.	 10	 and	Table	 2),	 which	 are	 consistent	with	 previous	 in	 vivo	 MRI	 (Daugherty	 and	 Raz,	2013;	 Li	 et	 al.,	 2014;	 Poynton	 et	 al.,	 2015;	 Rodrigue	 et	 al.,	 2013;	 Acosta-Cabronero	et	al.	2016)	and	post-mortem	iron	analyses	(Hallgren	and	Sourander,	1958;	Ramos	et	al.,	2014).	Furthermore,	 the	findings	presented	here	also	agree	with	 the	 aforementioned	 studies	 in	 that	 independent	 of	 age,	 the	 basal	 ganglia	system,	 RN	 and	 cerebellar	 DN	 contain	 more	 iron	 than	 the	 thalamus,	hippocampus,	amygdala,	isocortex	and	WM.			The	 age-related	 differences	 reported	 with	 QSM	 in	 deep	 brain	 nuclei	 such	 as	putamen,	 caudate,	 STN,	 SN,	RN,	 hippocampus	 and	DN	were	 in	 the	main	highly	concordant	with	R2*.	The	striking	exception	to	this	agreement	was	an	apparent	age-related	R2*	increase	in	the	GP,	which	was	found	to	be	exclusively	restricted	to	the	external	segment	(GPe,	Fig	4	and	Table	2).	In	contrast,	the	GP	result	with	QSM,	whilst	 rich	 in	 iron	 in	 absolute	 terms,	did	not	demonstrate	 an	age-related	increase.	 The	 high	 R2*	 values	 for	 the	 GP	 (independent	 of	 age)	 in	 contrast	 to	thalamus,	caudate	and	putamen	are	consistent	with	previous	in	vivo	R2*	reports	and	 post-mortem	 correlations	 with	 iron	 concentration	 (Gelman	 et	 al.,	 1999;	Langkammer	et	al.,	2010;	Péran	et	al.,	2009;	Yao	et	al.,	2009).	Furthermore,	age-related	increase	in	R2*	have	been	reported	previously	in	the	GP	in	some	studies	(Callaghan	et	al.,	2014;	Draganski	et	al.,	2011).	On	the	other	hand,	 the	 lack	of	a	significant	 age-related	 difference	 in	 the	 GP	 with	 QSM	 in	 the	 present	 study	 is	consistent	with	previous	post-mortem	evidence	(Hallgren	and	Sourander,	1958),	and	confirmed	 in	vivo	 (Li	et	al.,	2014),	 that	 iron	deposition	 in	 the	GP	 increases	rapidly	 from	 birth	 until	 the	 second	 decade	 of	 life	 but	 thereafter	 plateaus.	 One	study,	however,	reported	age-related	differences	in	the	GPe—but	not	GPi—with	
	 35	
QSM	 (Ide	 et	 al.,	 2015).	 Overall,	 the	 differential	 GP	 behaviours	 in	 the	 present	study	 are	 reflected	 in	 the	 existing	 literature,	 indeed	 a	 meta-analysis	 of	 past	studies	 using	 various	MR	 techniques	 to	 estimate	 iron	 content	 (Daugherty	 and	Raz,	 2013)	 concluded	 that	 the	 GP	 showed	 the	 weakest	 and	most	 inconsistent	age-related	 differences	 compared	 to	 other	 basal	 ganglia	 structures.	 One	possibility	 for	such	inconsistency	 in	past	studies,	could	have	been	the	presence	of	 pre-clinical	 neurodegenerative	 diseases	 in	 older	 subjects,	 but	 this	 cannot	explain	the	present	discrepancy	between	R2*	and	QSM	which	were	derived	from	precisely	 the	 same	 cohort.	 If	 it	were	 the	 case	 that	 the	 R2*	 GPe	 increase	 in	 the	present	 study	 were	 not	 spurious,	 one	 possible	 explanation	 for	 the	 absence	 of	QSM	effects	could	be	that	age-related	pallidal	micro-calcifications	may	cancel	out	increased	paramagnetism	driven	by	iron	accumulation.	Owing	to	its	diamagnetic	properties,	 calcium	 deposition	 may	 attenuate	 intra-voxel,	 age-related	 QSM	increases	due	to	its	negative	effect	on	total	susceptibility.	Whether	it	is	plausible	that	pallidal	calcification	affects	only	the	GPe	and	not	GPi	is	another	matter,	but	it	is	 at	 least	 theoretically	 possible.	 All	 of	 these	 scenarios	 are,	 of	 course,	 only	speculations	 at	 present;	 the	 key	 conclusion	 from	 this	 result	 is	 that	 age-related	differences	pertaining	to	iron	concentration	in	the	GP	should	be	interpreted	with	extreme	 caution	 until	 more	 information	 is	 available,	 particularly	 from	 studies	with	ex	vivo	verification	across	the	adult	lifespan.		It	 is	 also	known	 that	QSM	and	R2*	are	affected	by	myelin	density	variations	 in	contrasting	 ways	 (Li	 et	 al.,	 2012;	 Liu,	 2010;	 Liu	 et	 al.,	 2011;	 Schweser	 et	 al.,	2011),	 chiefly	 modulated	 by	 myelin	 lipid/iron	 interactions	 (Fukunaga	 et	 al.,	2010).	 It	 is	noteworthy	 that	 the	amount	of	myelin	varies	substantially	 in	areas	with	high	iron	concentration	as	indicated	by	myelin	stains	(Schaltenbrand	et	al.,	1977;	 Deistung	 et	 al.,	 2013),	 magnetisation	 transfer	 (MT;	 reflecting	 loss	 of	macromolecular	content)	(Anik	et	al.,	2007)	and	proton-induced	X-ray	emission	(PIXE)	maps	 (Stüber	 et	 al.,	 2014).	 In	 this	 scenario	 the	presence	of	myelin	may	also	 locally	 attenuate	 susceptibility	 values,	 thus,	 it	 is	 plausible	 that	 in	 such	regions,	 QSM	 may	 underestimate	 the	 true	 impact	 of	 iron	 accumulation.	 In	contrast,	 tissue	myelination	 in	R2*	maps	would	 lead	to	overestimated	values	of	iron	content	(Deistung	et	al.,	2013).	A	recent	study	using	MT	in	aging	identified	a	significant	 age-related	 decrease	 in	 the	 thalamus	 indicative	 of	 a	 reduction	 in	macromolecular	content	–	typically	myelin	(Callaghan	et	al.,	2014).	Furthermore,	the	 substantial	 age-related	 differences	 reported	 here	 in	WM	with	 signed	 QSM	namely	 in	 the	 corpus	 callosum	 and	 posterior	 thalamic	 radiation	 are	 also	consistent	with	whole-brain	decreases	in	MT	reported	by	Callaghan	et	al.,	2014,	which	may	further	point	towards	age-related	differences	in	demyelination.	This	may	explain	the	present	findings	in	that	although	both	R2*	and	QSM	found	strong	age-related	increases	in	most	subcortical	structures	beyond	the	mesencephalon,	QSM	values	were	overall	lower	than	those	in	the	SN.	For	instance,	using	R2*,	the	STN	 exhibited	 similar	 values	 to	 SN	 and	 RN,	whereas	with	 QSM,	 even	 absolute	values	 were	 relatively	 attenuated	 (Fig.	 10).	 It	 could	 be,	 therefore,	 that	 in	 the	STN—but	 also	 corpus	 striatum,	 hippocampus,	 amygdala,	 thalamus	 and	 DN—demyelination	may	have	modulated	QSM	but	again,	this	is	only	speculation	at	the	present	time.	It	is	interesting,	additionally,	that	most	of	these	structures	(except	STN,	 GP	 and	 amygdala)	 also	 returned	 significantly	 smaller	 age-related	differences	 for	 signed—relative	 to	 absolute—QSM	 values,	 which	 also	 suggests	
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that	 the	 diamagnetic	 component	 in	 age-related	 magnetic	 susceptibility	 effects	might	not	be	negligible.			In	 contrast,	 both	 absolute	 and	 signed	 QSM,	 revealed	 superior	 sensitivity	 in	detecting	 age-related	 differences	 in	 the	 thalamus:	 increased	 susceptibility	 in	posterior,	medial	and	anterior	sub-nuclei;	decreased,	in	the	lateral	group	(Figs.	6	and	 7).	 With	 the	 exception	 of	 the	 pulvinar,	 however,	 no	 such	 differences	(increase	 or	 decrease)	were	 observed	with	 R2*.	 These	 findings	 are	 in	 keeping	with	 a	 previous	 study	 that	 showed	 QSM	 to	 be	 superior	 to	 R2*	 in	 delineating	thalamic	 sub-nuclei	 (Deistung	 et	 al.,	 2013).	 Moreover,	 recent	 findings	 have	shown	 an	 age-related	 decrease	 in	MT	 in	 the	 thalamus	 (Callaghan	 et	 al.,	 2014),	thought	 to	 reflect	 concomitant	demyelination,	which	may	also	be	an	 indication	that	QSM	is	a	superior	contrast	to	capture	such	phenomenon.			 	The	 impact	 of	 age	 on	 myelination	 status	 is	 complex	 to	 interpret	 since	 whilst	myelin	 sheaths	 are	 seen	 to	 degenerate	 with	 age,	 the	 process	 of	 myelin	production	 continues	 throughout	 life	 (Peters,	 2002).	 Furthermore,	oligodendrocytes	 are	 essential	 for	 the	 production	 and	 maintenance	 of	 myelin	and	require	iron	to	sustain	their	metabolic	rate	and	facilitate	synthesis	of	lipids	and	 cholesterol	 (Bartzokis,	 2011;	 Todorich	 et	 al.,	 2009).	 Under	 normal	conditions,	oligodendrocytes	strongly	stain	for	iron	in	the	human	brain	(Connor	et	 al.,	 1990;	 Gerber	 and	 Connor,	 1989;	 LeVine,	 1997;	 Morris	 et	 al.,	 1992).	However,	conditions	that	lead	to	iron	elevation	i.e.	aging,	are	also	associated	with	demyelination,	since	iron	is	released	by	damaged	oligodendrocytes	(Zecca	et	al.,	2004).	 Therefore,	 some	 of	 the	 age-related	 differences	 detected	with	 QSM	may	reflect	oligodendrocytic	alterations,	but	also	the	degree	of	myelination	due	to	the	determinative	 role	 of	 oligodendrocytes	 on	 myelin	 status.	 Future	 studies	combining	whole	brain	QSM	with	MT,	or	techniques	to	model	the	contributions	of	myelin	and	iron	in	MRI	tissue	contrasts	(Stüber	et	al.,	2014)	would	be	highly	desirable	 to	 clarify	 whether	 the	 present	 QSM/R2*	 differential	 behaviors	 are	driven	by	demyelination,	calcification	or	some	other	process.		The	strength	of	the	whole-brain	approach	presented	here	is	that	it	identified	age-related	 phenomena	 beyond	 those	 in	 pre-determined	 ROIs.	 The	 most	 striking	QSM	behaviour	was	 an	 extensive	 effect	 in	 the	dorsal	 frontal	 lobe,	 particular	 in	the	motor	 cortices	 but	 also	 bilateral	 insula	 and	 cerebellar	 cortex.	 Additionally,	QSM	 effects	 in	 superior	 frontal	 regions	 were	 not	 restricted	 to	 GM,	 revealing	extensive	age-related	differences	 in	WM.	 In	stark	contrast,	 the	R2*	whole-brain	analysis	revealed	no	such	effects	in	cerebral	WM	except	for	very	focal	effects	in	the	fornix,	which	could	be	artefactual	due	to	its	small	size	and	proximity	to	CSF,	and	cerebral/cerebellar	peduncles.	This	would	suggest	the	extensive	age-related	differences	in	WM	with	QSM	could	be	due	to	its	superior	sensitivity	to	combined	myelin/iron	alterations	but	 it	could	also	be	artefactual	as	previously	discussed.	However,	 one	 should	 note	 that	 a	 recent	 aging	 study	 reporting	 an	 age-related	decrease	in	frontal	WM	using	MT	supports	the	validity	of	the	former	hypothesis	(Callaghan	et	al.,	2014).			Turning	to	GM,	an	interesting	finding	was	that	the	human	cortex	in	older	adults	appeared	 to	mineralise	 unevenly.	 This	 is	 an	 important	 result	 because	 seminal	
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work	 from	Hallgren	 and	 Sourander	 (1958)	 but	 also	 in	vivo	evidence	 using	 T2*	(Hasan	et	al.,	2012),	has	suggested	that	there	might	be	a	graded	behaviour	across	cerebral	lobes,	i.e.	greatest	iron	deposition	as	a	function	of	age	in	motor	cortex,	followed	 by	 occipital,	 parietal,	 temporal	 and	 finally,	 prefrontal	 regions.	 While	this	 might	 hold	 true	 globally,	 the	 present	 whole-brain	 data	 also	 revealed	 that	iron	accumulation	in	older	adults	might	be	more	focally	specific	than	anticipated.	Evidence	supporting	this	observation	was	that	cortical	structures	across	all	lobes	were	 between	 those	 that	 returned	 the	 strongest	 age-related	 differences	 both	using	absolute	QSM	and	R2*.	An	exception	–	analogous	to	that	observed	in	the	GP	but	 opposite	 to	 that	 in	 the	 thalamus	 –	 is	 that	 QSM,	 but	 not	 R2*,	 remained	relatively	unchanged	across	the	occipital	cortex.	We	have	no	explanation	for	this	behaviour	at	present	time,	though	it	might	be	that	studying	the	differential	aging	effects	 returned	 by	 these	 three	 structures	 (i.e.	 seemingly	 different	 biological	scenarios)	 might	 offer	 some	 clues	 to	 deepen	 knowledge	 on	 the	 interplay	between	fundamental	magnetic	properties	in	biological	tissue.		It	 is	 important	 to	 note	 several	 limitations	 on	 interpretation	 of	 these	 findings.	First,	we	can	only	infer	age-related	differences	from	a	cross-sectional	study	and	cannot	comment	on	lifespan	trajectories	of	brain	mineralisation	–	an	interesting	area	for	future	research.	Second,	we	must	also	acknowledge	that	our	sample	size	(N=40)	may	 have	 limited	 our	 ability	 to	 detect	 age-related	 QSM/R2*	 sensitivity	differences;	 however,	 it	 is	 reassuring	 the	QSM	effects	 reported	here	 are	highly	concordant	 with	 those	 from	 a	 recent	 3T	 QSM	 study	 in	 a	 much	 larger	 cohort	(Acosta-Cabronero	 et	 al.,	 2016).	 Third,	 the	 reliability	 analysis	 revealed	 ICCs	 in	the	DN,	SN	and	STN	were	below	the	typical	guideline	of	reliability	-	 ICC	>	0.85,	thus	age-related	differences	reported	in	these	regions	should	be	interpreted	with	caution	 at	 present.	 As	 such,	 the	 relative	 attenuation	 of	 STN	 values	 with	 QSM	compared	to	R2*	for	example,	may	be	due	to	the	differential	unreliability	of	these	two	measures	 in	 this	 region.	Equally,	 differential	 effects	between	QSM	and	R2*	observed	 in	 the	 cortex	may	also	be	driven	by	 low	measurement	 reliability	and	whilst	unlikely,	it	could	also	have	contributed	to	the	lack	of	pallidal	effects	with	QSM.	Generally	differential	 unreliability	must	 also	be	 considered	 in	 accounting	for	 contrasting	QSM	 and	R2*	 effects.	 Fourth,	 ROI	 extractions	 taken	 from	 small	regions	of	the	cortex	may	be	more	prone	to	systematic	error	as	the	accuracy	of	quantified	 susceptibility	decreases	when	 the	 size	of	 the	 structure	of	 interest	 is	small	(Hsieh	et	al.,	2015),	which	may	be	exacerbated	in	older	subjects	with	age-related	 atrophy.	 However	 it	 is	 highly	 unlikely	 atrophy	 alone	 is	 driving	 effects	observed	in	cortical	regions	since	taken	as	a	whole,	group	differences	cannot	be	explained	 in	 terms	 of	 global	 atrophy.	 Fifth,	 the	 markedly	 reduced	 age-related	QSM/R2*	 effects	 in	 the	 ventral	 PFC	 compared	 to	 dorsal	 regions	 may	 reflect	relative	sparing,	however	this	may	be	a	technical	constraint	due	to	signal	loss	in	areas	 close	 to	 air/bone	 interfaces	 such	 as	 the	 ventral	 PFC	 which	 lies	 directly	above	 the	 nasal	 cavity.	 Finally,	 it	 must	 be	 noted	 that	 QSM	 may	 also	 be	implemented	using	single-echo	susceptibility	weighted	scans	(Acosta-Cabronero	et	al.,	2013;	Deistung	et	al.,	2013).	Single-echo	QSM	is	an	attractive	method	–	the	inherently	 improved	 signal-to-noise	 ratio	 at	 ultra-high	 field	 allows	 for	 higher	spatial	 resolution,	 shorter	 echo	 times	 (since	phase	 scales	 linearly	with	Bo×TE),	reducing	repetition	time	and	ultimately,	scan	time,	which	can	be	reduced	further	with	 parallel	 imaging	 techniques.	 It	 is	 currently	 unclear,	 however,	 how	 the	
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present	 whole-brain	 findings	 may	 compare	 to	 higher	 resolution	 QSM	 maps	derived	from	such	acquisitions,	particularly	in	regions	where	R2*	demonstrated	superior	sensitivity	with	the	present	multi-GRE	acquisition.	
	
5.	CONCLUSIONS		
In	vivo	high-resolution	QSM	using	ultra-high	field	MRI	and	a	relatively	unbiased	whole-brain	analysis	approach	is	a	useful	tool	for	assessing	subtle	variations	in	tissue	 composition	 and	 microstructure.	 The	 present	 study	 demonstrated	 QSM	can	potentially	advance	our	current	understanding	of	iron	dysregulation	in	aging	and	related	disorders;	but	also	showed	that	combining	QSM	and	R2*	using	multi-GRE	 imaging	 can	 provide	 a	 more	 complete	 picture	 of	 mineralisation	 and	demyelination	in	the	aging	human	brain.	To	take	this	forward,	it	will	be	critical	to	understand	what	drives	certain	brain	regions,	most	notably	the	GP,	thalamus	and	occipital	cortex,	to	exhibit	different	behaviour	with	the	two	techniques.	
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